abstract |
Formulations containing a sodium-hydrogen exchanger-1 inhibitor (NHE-1) for the prevention, among others, of peri-operative ischemic myocardial lesion in mammals and a procedure for increasing the solubility of said inhibitor with methanesulfonic acid. |